Safety and Efficacy of Mepolizumab in Patients with Eosinophilic Granulomatosis with Polyangiitis

Table 2

Baseline characteristics of patients included in selected studies.

Study	Mean age; (years)	Mean FEV1; (percentage)	Eosinophil count	Mean corticosteroid dose (mg)	BVAS	CRP; (mg/L)	ESR; (mm/hr)
Wechsler et al. [14]	CASE: 49; CONTROL: 48	NA	AEC per cubic millimeter; CASE: 177; Control: 172	12; 11	NA	NA	NA
Kim et al. [16]	45	76	3.4 %	12.9	6.9	3.9	7
Moosig et al. [15]	62	76.24	AEC per cubic millimeter: 539	18	6.9	0.68	22.7